Ordopidine

N/A

Report date: 2024/08/26 15:01:27
NME

Base Information

Drug NameOrdopidine
Drug Alias Name奥多匹定ordopidinaordopidinum奥度哌啶ACR-325
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNeurosearch As
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurosearch As
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A